Form D — Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
0002138549-26-000001 · filed Jul 8, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1
- Reported offering amount
- $1,000,000
- Reported amount sold
- $597,000
- Minimum investment
- $10,000
- Investors
- 15
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
- CIK
- 2138549
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 107 KILMAYNE DRIVE
CARY, NC 27511 - Phone
- 9193356001
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Michael Harlow · DirectorClayton, NC Find on LinkedIn ↗
-
Robert Earl Ross · DirectorCary, NC Find on LinkedIn ↗
-
John Powell Leachman · DirectorGainesville, GA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗